Citations 1
Phase II evaluation of dacarbazine (D), mitomycin-C (M), doxorubicin (A) and cisplatin (P) (DMAP) plus sargramostim (GM-CSF) in the treatment of advanced, persistent, or recurrent leiomyosarcoma of the uterus: A Gynecologic Oncology Group (GOG) study
Long, Harry J., Blessing, John A., Sorosky, Joel I.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 5077-5077
